{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:08:29Z","timestamp":1779448109792,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018636","name":"Xuzhou Science and Technology Plan Project","doi-asserted-by":"crossref","award":["KC22096"],"award-info":[{"award-number":["KC22096"]}],"id":[{"id":"10.13039\/501100018636","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722674"],"award-info":[{"award-number":["2022M722674"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xuzhou Medical Reserve Talents Project","award":["XWRCHT20220009"],"award-info":[{"award-number":["XWRCHT20220009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bladder cancer is one of the most prevalent malignancies of the urinary system, and its global incidence is rising, particularly among males. Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) plays a central role in enabling tumor cells to adapt to hypoxic conditions; however, its specific mechanisms of action in bladder cancer remain incompletely understood. This study aimed to investigate the effects of HIF-1\u03b1 knockdown on bladder cancer cell proliferation, apoptosis, migration, invasion, and angiogenesis. The T24 and 5637 bladder cancer cell lines were employed. Specific si-HIF-1\u03b1 plasmids were constructed and transfected into the cells. A series of functional assays were conducted, including MTT viability tests, flow cytometry for apoptosis analysis, Transwell migration and invasion assays, and in vitro angiogenesis experiments. Western blotting was performed to analyze the expression of tissue inhibitor of metalloproteinase 3 (TIMP3). Subsequent functional rescue experiments were carried out by overexpressing TIMP3. Additionally, clinical tissue samples were collected to assess the levels of HIF-1\u03b1 and TIMP3. The results showed that under hypoxic conditions, knockdown of HIF-1\u03b1 enhanced bladder cancer cell proliferation, migration, invasion, and angiogenesis while suppressing apoptosis. Furthermore, hypoxia was found to suppress TIMP3 expression in HIF-1\u03b1-knockdown cells. Notably, overexpression of TIMP3 reversed the alterations in bladder cancer cell behavior induced by HIF-1\u03b1 knockdown. Analysis of clinical samples revealed that HIF-1\u03b1 levels were significantly elevated in bladder cancer tissues. These findings uncover a complex regulatory role for HIF-1\u03b1 in bladder cancer and identify TIMP3 as a critical mediator of its effects. Further studies are warranted to elucidate the transcriptional regulation of TIMP3 by HIF-1\u03b1 and to validate its role in vivo, which may contribute to the advancement of targeted therapeutic strategies for bladder cancer.<\/jats:p>","DOI":"10.1038\/s41598-026-39635-9","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:24:55Z","timestamp":1770881095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-inducible factor 1\u03b1 exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoxian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"39635_CR1","doi-asserted-by":"publisher","unstructured":"Siegel, R. L. et al. Cancer statistics. CA Cancer J. Clin. 75 (1), 10\u201345. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","DOI":"10.3322\/caac.21871"},{"issue":"6","key":"39635_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo, N. et al. Epidemiology, Screening, and prevention of bladder cancer. Eur. Urol. Oncol. 5 (6), 628\u2013639. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003 (2022).","journal-title":"Eur. Urol. Oncol."},{"issue":"7","key":"39635_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo, C. C. et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat. Rev. Urol. 21 (7), 391\u2013405. https:\/\/doi.org\/10.1038\/s41585-023-00847-7 (2024).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"39635_CR4","doi-asserted-by":"publisher","first-page":"2440165","DOI":"10.1080\/21645515.2024.2440165","volume":"21","author":"E Tassinari","year":"2025","unstructured":"Tassinari, E. et al. State of the Art of adjuvant immunotherapy in urothelial cancer: new developments and upcoming changes. Hum. Vaccin Immunother. 21 (1), 2440165. https:\/\/doi.org\/10.1080\/21645515.2024.2440165 (2025).","journal-title":"Hum. Vaccin Immunother"},{"issue":"9","key":"39635_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/iju.14288","volume":"27","author":"AB Weiner","year":"2020","unstructured":"Weiner, A. B. et al. Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a National cohort. Int. J. Urol. 27 (9), 736\u2013741. https:\/\/doi.org\/10.1111\/iju.14288 (2020).","journal-title":"Int. J. Urol."},{"issue":"9","key":"39635_CR6","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/1878-0261.13684","volume":"18","author":"I Kawahara","year":"2024","unstructured":"Kawahara, I. et al. Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models. Mol. Oncol. 18 (9), 2196\u20132211. https:\/\/doi.org\/10.1002\/1878-0261.13684 (2024).","journal-title":"Mol. Oncol."},{"issue":"5","key":"39635_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel, V. G., Oh, W. K. & Galsky, M. D. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J. Clin. 70 (5), 404\u2013423. https:\/\/doi.org\/10.3322\/caac.21631 (2020).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"39635_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","volume":"11","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., Xing, C., Deng, Y., Ye, C. & Peng, H. HIF-1\u03b1 signaling: essential roles in tumorigenesis and implications in targeted therapies. Genes Dis. 11 (1), 234\u2013251. https:\/\/doi.org\/10.1016\/j.gendis.2023.02.039 (2023).","journal-title":"Genes Dis."},{"issue":"11","key":"39635_CR9","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.3390\/ijms22115703","volume":"22","author":"V Infantino","year":"2021","unstructured":"Infantino, V., Santarsiero, A., Convertini, P., Todisco, S. & Iacobazzi, V. Cancer cell metabolism in hypoxia: role of HIF-1 as key regulator and therapeutic target. Int. J. Mol. Sci. 22 (11), 5703. https:\/\/doi.org\/10.3390\/ijms22115703 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"39635_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong, S. et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J. Exp. Clin. Cancer Res. 41 (1), 15. https:\/\/doi.org\/10.1186\/s13046-021-02229-6 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"39635_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee, J. W., Bae, S. H., Jeong, J. W., Kim, S. H. & Kim, K. W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (1), 1\u201312. https:\/\/doi.org\/10.1038\/emm.2004.1 (2004).","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"39635_CR12","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/ijms25073735","volume":"25","author":"J Sun","year":"2024","unstructured":"Sun, J. et al. The tumor microenvironment mediates the HIF-1\u03b1\/PD-L1 pathway to promote immune escape in colorectal cancer. Int. J. Mol. Sci. 25 (7), 3735. https:\/\/doi.org\/10.3390\/ijms25073735 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"39635_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/neup.12111","volume":"34","author":"CA Clara","year":"2014","unstructured":"Clara, C. A. et al. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1\u03b1 in human glioblastoma. Neuropathology 34 (4), 343\u2013352. https:\/\/doi.org\/10.1111\/neup.12111 (2014).","journal-title":"Neuropathology"},{"issue":"11","key":"39635_CR14","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.tranon.2020.100845","volume":"13","author":"K Saxena","year":"2020","unstructured":"Saxena, K., Jolly, M. K. & Balamurugan, K. Hypoxia, partial EMT and collective migration: emerging culprits in metastasis. Transl Oncol. 13 (11), 100845. https:\/\/doi.org\/10.1016\/j.tranon.2020.100845 (2020).","journal-title":"Transl Oncol."},{"issue":"4","key":"39635_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin, E. B. & Giaccia, A. J. The role of hypoxia-inducible factors in tumorigenesis. Cell. Death Differ. 15 (4), 678\u2013685. https:\/\/doi.org\/10.1038\/cdd.2008.21 (2008).","journal-title":"Cell. Death Differ."},{"issue":"5","key":"39635_CR16","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1053\/j.gastro.2020.07.046","volume":"159","author":"A Tiwari","year":"2020","unstructured":"Tiwari, A. et al. Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis. Gastroenterology 159 (5), 1882\u20131897e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.046 (2020).","journal-title":"Gastroenterology"},{"issue":"7","key":"39635_CR17","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1007\/s13277-015-4757-4","volume":"37","author":"XG Han","year":"2016","unstructured":"Han, X. G. et al. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances. Tumour Biol. 37 (7), 8857\u20138867. https:\/\/doi.org\/10.1007\/s13277-015-4757-4 (2016).","journal-title":"Tumour Biol."},{"issue":"27","key":"39635_CR18","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1038\/onc.2011.18","volume":"30","author":"MC Anania","year":"2011","unstructured":"Anania, M. C. et al. TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. Oncogene 30 (27), 3011\u20133023. https:\/\/doi.org\/10.1038\/onc.2011.18 (2011).","journal-title":"Oncogene"},{"issue":"1","key":"39635_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12935-024-03454-7","volume":"24","author":"S Zhan","year":"2024","unstructured":"Zhan, S. et al. TGFBI promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through PI3K\/AKT\/mTOR\/HIF-1\u03b1 pathway. Cancer Cell. Int. 24 (1), 265. https:\/\/doi.org\/10.1186\/s12935-024-03454-7 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"39635_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12957-017-1163-y","volume":"15","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Clinical and prognostic significance of HIF-1\u03b1 overexpression in oral squamous cell carcinoma: a meta-analysis. World J. Surg. Oncol. 15 (1), 104. https:\/\/doi.org\/10.1186\/s12957-017-1163-y (2017).","journal-title":"World J. Surg. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39635-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:46:43Z","timestamp":1779446803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39635"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39635-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article the affiliation 'Department of Urology, Zhongwu Hospital. No. 86, Xiamen Road, Suqian, Jiangsu, China,' was incorrectly given as \u201cDepartment of Urology, Zhongwu Hospital, No. 15, Huating Road, Xinyi, Jiangsu, China.\u201d Also the funding information section was missing and this now reads, \u201cThis work was supported by The National Natural Science Foundation(82004110); China Postdoctoral Science Foundation(2022M622674); Xuzhou Medical Reserve Talents Project (XWRCHT20220009); Suqian Municipal Bureau of Science and Technology Project(s202205).\u201dThe original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8425"}}